FDA Inspection 732616 — Merck Serono SA
The FDA completed an inspection of Merck Serono SA on June 16, 2011 in Aubonne. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 16, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aubonne (Switzerland)